Interviews with Malaria Stakeholders
Topics:
All, Academia, Africa, Charity, Diagnosis, Drug Safety, Education, Entrepreneurship, Equality, Funding, Larvicides, Medicine, Mosquito Nets, New Technologies, Politics, Research & Development
An interview with Dr Melanie Renshaw, Chief Policy Officer of the RBM Partnership to End Malaria, to discuss progress against malaria, the funding gap and how access to core malaria interventions will be maintained during the COVID pandemic.
To take a look at where we are in the fight against malaria, I’m joined by Michal Fishman of Malaria No More. She’s co-chairs RBM’s Strategic Communications Partner Committee, which brings together organisations to reduce the malaria burden.
In 2018, leaders of the Commonwealth countries pledged to reduce malaria cases by half by 2023. One year on, what has been done to try and achieve that aim? Malaria No More held a panel in London to try and answer that very question.
The Strategic Communications Partner Committee wants to align the global malaria community with key messaging to catalyse action. I speak with Xenya Scanlon, the committee’s manager, at the time of their Annual Meeting.
Ms Mordaunt tells me about the UK’s efforts to fight malaria, the Commonwealth and the level of collaboration between DFID and the Gates Foundation.
Political attitudes are vital to the success of malaria elimination efforts. Jeremy Lefroy’s responsibility is to inform other Parliamentarians about the disease.
Stellar Murumba has been investigating substandard antimalarial drugs. Her work has led to the Kenyan Health Ministry to recall Duo-Cotecxin, a commonly used antimalarial.
Margaret Reilly McDonnell, the Executive Director of Nothing But Nets discusses the importance of mosquito nets, the growing issue of insecticide resistance and cuts to foreign aid.